Most Read Articles
31 May 2016
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Rachel Soon, 12 Dec 2018

MIMS Pharmacist presents an overview of superoxide dismutase (SOD) and its role in resisting the effects of oxidative stress and aging.

Rachel Soon, 25 Jul 2018

MIMS Pharmacist presents an overview of Lactobacillus plantarum 299v's physiological role, as well as contemporary research on its pharmacology and effects.

01 Mar 2018
Lifetime prevalence of acute pain leading to the use of analgesics approaches 100% in the general population, and pharmacists are a pivotal first point of contact for patients in their journey to better pain management. Noting the need for pharmacists to be more aware of their evolving role as a community pharmacist, GlaxoSmithKline Consumer Healthcare partnered with MIMS Education to organize a workshop that served as a platform for robust knowledge-sharing. Below are highlights from the workshop.

Antituberculosis treatment halves risk of uveitis recurrence

25 Apr 2018

In patients with latent tuberculosis (TB)-associated uveitis, treatment with an anti-TB drug cuts the risk of uveitis recurrence by half and delays the onset of first recurrence, as reported in a recent study.

Researchers looked at 199 eyes of 129 patients, of whom 89 patients (69 percent) received anti-TB treatment. Uveitis was managed using local and systemic anti-inflammatory and immunosuppressive therapy.

Data on clinical outcome, vision and treatment were gathered and analysed. Outcomes of interest included best corrected visual acuity (BCVA) and rate of disease recurrence.

Over the follow-up period, mean change in BCVA following treatment was 4.5±1.4 letters. No significant difference was observed between eyes of patients receiving anti-TB treatment and those who did not.

Uveitis recurrence occurred in 68 eyes (34.9 percent; 0.64±0.08 recurrences per year), with eyes of patients receiving anti-TB treatment less likely to develop a recurrence (29.5 percent vs 48.2 percent).

Specifically, anti-TB treatment reduced the odds of developing recurrence by more than half (odds ratio, 0.47; 95 percent CI, 0.29–0.77; p=0.003). Eyes of patients who received the treatment recurred at an estimated median of 120 months vs 51 months in eyes of those who were not treated with an anti-TB drug (p=0.005).

The present data provide positive evidence of the benefit of treating latent TB-related uveitis with an anti-TB drug in addition to appropriate local and systemic anti-inflammatory therapy, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
31 May 2016
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Rachel Soon, 12 Dec 2018

MIMS Pharmacist presents an overview of superoxide dismutase (SOD) and its role in resisting the effects of oxidative stress and aging.

Rachel Soon, 25 Jul 2018

MIMS Pharmacist presents an overview of Lactobacillus plantarum 299v's physiological role, as well as contemporary research on its pharmacology and effects.

01 Mar 2018
Lifetime prevalence of acute pain leading to the use of analgesics approaches 100% in the general population, and pharmacists are a pivotal first point of contact for patients in their journey to better pain management. Noting the need for pharmacists to be more aware of their evolving role as a community pharmacist, GlaxoSmithKline Consumer Healthcare partnered with MIMS Education to organize a workshop that served as a platform for robust knowledge-sharing. Below are highlights from the workshop.